Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002049814 | SCV002111209 | uncertain significance | not provided | 2021-04-14 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C55"). This variant has not been reported in the literature in individuals with COL11A1-related conditions. This variant is present in population databases (rs760878512, ExAC 0.01%). This sequence change replaces glycine with serine at codon 667 of the COL11A1 protein (p.Gly667Ser). The glycine residue is highly conserved and there is a small physicochemical difference between glycine and serine. |
Gene |
RCV002049814 | SCV005377656 | uncertain significance | not provided | 2023-12-09 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 25240749) |
Genomic Medicine Center of Excellence, |
RCV004813191 | SCV005438440 | uncertain significance | Stickler syndrome type 2 | 2024-12-18 | criteria provided, single submitter | clinical testing |